Perrigo Co Plc - Company Profile
Powered by 
All the data and insights you need on Perrigo Co Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Perrigo Co Plc Strategy Report
- Understand Perrigo Co Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Perrigo Co Plc (Perrigo) develops and manufactures generic and prescription (Rx) drugs, active pharmaceutical ingredients (API) and consumer products. The company classifies its operations into two business segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI).
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Perrigo’s R&D focuses on the new products development and enhancement of existing products. The company collaborates with other pharmaceutical companies to develop, manufacture, and market groups of products. In FY2022, the company incurred an expense of US$123.1 million on R&D, which as a percentage of revenue stood at 2.8%.
Business Segments
Overview
Comprises its consumer self-care business. Develops, manufacturers and markets OTC (over the counter) products in the US, Canada, and Mexico. Offers OTC store brand products including analgesics, cough, cold, allergy and sinus, gastrointestinal, smoking cessation, infant formula and foods, oral self-care products and diagnostic products. The segment categorizes its product in categories: Pain and sleep-aids, Upper respiratory, Digestive health, Nutrition, Healthy lifestyle, Skincare and personal hygiene, Oral self-care, Vitamins, minerals and supplements (VMS), and others. This segment also includes OTC contract manufacturing.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Develops, manufactures, markets and distributes branded OTC products primarily in Australia and Europe, store-brand business in the UK and parts of Asia and Europe. The segment categorizes its product in categories: Pain and sleep-aids, Upper respiratory, Digestive health, Healthy lifestyle, Skincare and personal hygiene, Oral self-care, Vitamins, minerals and supplements (VMS) and other. The company distrusted these products through an extensive network of pharmacies in more than 30 countries in Europe.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Target Markets
Israel, Mexico, Australia, and Canada.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer